Vivanza Biosciences share news, announcements and annual reports
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Vivanza Biosciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last close ₹1.54up ₹0.11 (7.69%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.43.
30 Oct: open ₹1.50, high ₹1.60, low ₹1.50
52-week range of traded prices to 30 Oct 2026
₹1.30Low, 26 Oct 2026₹2.72High, 17 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.16 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 24,333
Vivanza Biosciences board meetings
153 filed, newest first. Page 3 of 4.
Sep 2020
15 Sep · Board meeting
8 Sep · Board meeting
8 Sep · Board meeting
Meeting on 15 Sep 2020: quarterly results
Jul 2020
27 Jul · Board meeting
Meeting on 30 Jul 2020: audited results
Jun 2020
26 Jun · Board meeting
Jan 2020
20 Jan · Board meeting
Meeting on 28 Jan 2020: quarterly results
Nov 2019
12 Nov · Board meeting
4 Nov · Board meeting
Meeting on 12 Nov 2019: quarterly results
Sep 2019
Aug 2019
27 Aug · Board meeting
Meeting on 29 Aug 20192 Aug · Board meeting
Meeting on 8 Aug 2019: annual general meeting and quarterly results
May 2019
15 May · Board meeting
Meeting on 21 May 2019: audited results
Mar 2019
26 Mar · Board meeting
Meeting on 29 Mar 2019
Feb 2019
6 Feb · Board meeting
Meeting on 13 Feb 2019: quarterly results
Oct 2018
Aug 2018
Mar 2018
Aug 2017
Mar 2017
31 Mar · Board meeting
Aug 2016
Jun 2016
May 2016
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has: - Considered and approved changing the Registrar ....
Feb 2016
Jan 2016
27 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 27, 2016, inter alia, has transacted the following : - Authorised Directors ....
Nov 2015
3 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 03, 2015, took note of the resignation of statutory auditor'as of the Company, ....
Sep 2015
7 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 07, 2015, inter alia, has considered proposing to the members of the Company, ....
Aug 2015
14 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 14, 2015, inter alia, has proposed the Special Resolution under section 180 of ....
May 2015
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2015, inter alia has considered the Reduction of Capital from Rs. 3,76,00,000/- ....
Mar 2015
30 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 30, 2015, inter alia, has appointed Mrs. Sheetal Girish Pandya as Additional Director ....
Sep 2014
2 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 02, 2014, inter alia, has transacted the following business : - Recommend ....
Jul 2014
12 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 12, 2014, has considered and approved the revised Scheme of Arrangement.